In the second installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guest Thomas Burns.

• Welcome to the Eyeluminaries podcast 00:01
• Quick recap of Part 1 00:08
• Intro of Thomas Burns 00:30
• How do we foresee the adoption of IDose? 02:02
• Where do you see the field of keratoconus going? 04:36
• What advice do you have for young people just starting out? 08:36
• Who is a mentor for you? 11:06
• Do you have a good Jim Mazzo story? 15:38
• Thank you, Tom Burns 16:44
• Thank you! 17:11

Thomas Burns is the chairman and CEO of Glaukos.

We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X @DrHovanesian.

In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD.

• Welcome to the Eyeluminaries podcast 00:10
• Quick recap of episode 34 00:52
• Intro of Julia A. Haller, MD, CEO 01:47
• Tell us about changes you're seeing in leading a large academic center 02:16
• How has residency changed in the last years? 06:23
• Why are you involved in the Ophthalmology Foundation? 13:05
• Intro of David F. Chang, MD 16:51
• What do you think about the future of robotics in cataract surgery? 17:51
• How do you continue to involve the patient in their care? 20:15
• Dr. Chang discusses premium lenses 22:43
• What's going on with EyeSustain and what are you excited about in the future? 27:00
• Thank you! 35:30

Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital.

David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board.

We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit "Sam" Garg, MD and Jean-Pierre Hubschman, MD.

• Welcome to the Eyeluminaries podcast 00:05
• Review of episode 33 00:49
• Intro of Tibor Juhasz, PhD 01:35
• Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27
• How is ViaLase impacting glaucoma treatment? 06:55
• How the treatment works 08:24
• The importance of having a good team 11:02
• Intro of Richard L. Lindstrom, MD 12:58
• What is your perspective on what is happening today and what changes are you hoping for? 14:28
• Integrated eye care delivery 17:00
• Dentistry, a future model for eye care 17:50
• Post-graduate medical education is changing 19:09
• Was there a technology that you thought was a slam dunk and failed? 23:01
• Any technology that you didn't expect to take off? 24:37
• Intro of Sumit "Sam" Garg, MD 26:58
• What do you see changing in ophthalmology residency programs around the country? 28:52
• How do you instruct young physicians to be collaborative in care? 30:42
• If you weren't a cornea specialist (or a model) what would you be? 32:10
• Advice for young ophthalmologists today? 33:42
• Share a Jim Mazzo story with us! 35:28
• Intro of Jean-Pierre Hubschman, MD 37:07
• Why did you, with a robotics company, decide to start in cataract surgery? 38:23
• How do you become more efficient in robotic surgery? 41:00
• How do we work on the economic side of this? 43:38
• What's it like running a company vs being a retina surgeon? 44:46
• Give us your feedback 48:16
• Thanks for listening 48:30

Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS.

Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News.

Sumit "Sam" Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine.

Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.

We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian.

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.